17 material Form 8-K filings that 16 companies we cover made with the SEC in May 2023, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Franklin Resources and Great-West Lifeco said on May 31, 2023 they signed a definitive agreement for a Franklin Resources subsidiary to acquire Putnam U.S. Holdings I, LLC, the parent of Putnam Investment Management, which manages the Putnam funds including this trust. The deal is expected to close in the fourth quarter of 2023, subject to regulatory approvals and other customary conditions. Closing would automatically end the current investment management contract, so trustees must approve a new one and shareholders must vote on it.
Agreement announced May 31, 2023 for a stock and cash transaction
Closing expected in the fourth quarter of 2023, subject to regulatory approvals and customary conditions
Current management contract ends automatically at closing under the Investment Company Act of 1940
Trustees must approve a new management contract, which then goes to shareholders for approval
Franklin Resources and Great-West Lifeco agreed on May 31, 2023 that a Franklin Resources subsidiary will acquire Putnam U.S. Holdings I, LLC, the parent of Putnam Investment Management, the fund's investment manager, in a stock and cash transaction. Closing is expected in the fourth quarter of 2023, subject to regulatory approvals, and would end the current management contract, so the Board and shareholders would need to approve a new one.
Definitive agreement announced May 31, 2023 for a Franklin Resources subsidiary to acquire Putnam U.S. Holdings I, LLC in a stock and cash transaction
Putnam Investment Management, LLC would become an indirect wholly owned subsidiary of Franklin Resources
Transaction is expected to close in the fourth quarter of 2023, subject to customary conditions and regulatory approvals
Closing would automatically terminate the current investment management contract; a new contract requires Board approval and shareholder approval
On May 31, 2023, Franklin Resources and Great-West Lifeco agreed that a Franklin Resources subsidiary will acquire Putnam U.S. Holdings I, LLC, the parent of Putnam Investment Management, LLC, the investment manager of the Putnam funds, including this trust. Closing is expected in the fourth quarter of 2023, subject to regulatory approvals, and would end the current investment management contract, so the trust's board would need to approve a new one, which would then go to shareholders.
Agreement announced May 31, 2023: a Franklin Resources subsidiary to acquire Putnam U.S. Holdings I, LLC in a stock and cash transaction
Transaction currently expected to close in the fourth quarter of 2023, subject to regulatory approvals and other customary conditions
Closing would automatically terminate the current investment management contract between the trust and Putnam Investment Management, LLC
Trustees must approve a new management contract, which would then be presented to shareholders for approval
On May 31, 2023, Franklin Resources and Great-West Lifeco agreed that a Franklin Resources subsidiary will acquire Putnam Holdings in a stock and cash deal. Putnam Investment Management, which manages the Putnam funds including this trust, would become an indirect wholly owned subsidiary of Franklin Resources. Under the Investment Company Act of 1940, the deal would end the current management contract, so the fund's board and shareholders would need to approve a new one.
Agreement announced May 31, 2023, in a stock and cash transaction
Closing expected in the fourth quarter of 2023, subject to regulatory approvals and customary conditions
Current investment management contract terminates automatically at closing
Board of Trustees must approve a new management contract, which then goes to shareholders for approval
EUDA Health Holdings issued 2,317,606 restricted shares on May 16, 2023, to settle debts owed to a major shareholder, its CEO and related companies, and converted a $700,000 note into 700,000 shares. Between May 16 and May 22, 2023, it also sold 940,000 shares at $1.00 each to eight accredited investors for $940,000, which adds to the outstanding share count.
1,617,606 shares issued May 16, 2023, under five settlement agreements, including 850,306 shares to CEO Kelvin Chen to satisfy a $850,306 claim.
700,000 shares issued May 16, 2023, after James Tan converted a $700,000 note at $1.00 per share.
940,000 shares sold at $1.00 each, for $940,000, to eight accredited investors between May 16 and May 22, 2023.
None of the shares are registered under the Securities Act; the company agreed to register resale of the placement shares under registration rights agreements.
The fund filed an 8-K furnishing an investor presentation and a video transcript from a May 23, 2023 client event, with the video also emailed to attendees. The filing contains no financial results, fund performance figures, or changes to the fund, so it has no direct financial effect on shareholders.
Investor presentation furnished as Exhibit 99.1 and video transcript as Exhibit 99.2, both from a client event held May 23, 2023
Speakers were from TD Securities; the transcript discusses market conditions for physically backed gold ETFs, including an estimated $100 billion in US physical gold ETF assets under management
The filing is furnished under Regulation FD and is not deemed filed for Section 18 purposes; the signature block is dated May 23, 2022
The sponsor, Merk Investments, said the Trust will replace the LBMA PM Gold Price with the Solactive Gold Spot Index to value its gold, effective July 11, 2023 or as soon as practicable after. The sponsor says the change could result in materially different net asset values for the Trust, and that the new index is priced around the NYSE close, which it believes better aligns NAV with U.S. trading hours.
Benchmark changes from the LBMA PM Gold Price to the Solactive Gold Spot Index (SOLAGOLD) effective July 11, 2023 or as soon as practicable thereafter
The Bank of New York Mellon, the Trust's trustee, has been instructed to use SOLAGOLD for NAV from the change date; NAV uses the LBMA PM Gold Price until then
The filing states the change could result in materially different net asset values for the Trust
Director George Lowell resigned from the board of directors effective May 12, 2023, after serving since 2008. The filing states he did not resign over any disagreement with the company, and he will remain on the Scientific Advisory Board as a liaison between that board and the Board. The filing names the registrant as BiondVax Pharmaceuticals Ltd.; the company and Mr. Lowell are still negotiating his compensation for the new roles.
Mr. Lowell submitted his board resignation on May 10, 2023, effective May 12, 2023
He had served as a Board member since 2008; the Board chairman, Mark Germain, thanked him for 15 years of service
Mr. Lowell will stay on the Scientific Advisory Board and become a liaison between it and the Board
Compensation for his continuing and new roles is still under discussion
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.